Logic-gated nanoregulators: A paradigm shift from drug delivery to pre-programmed multi-target immunotherapy.
This review traces the evolution of nanomedicine from a passive drug delivery vehicle to a therapeutic program encoded in a physical structure, and examines the design constraints that will determine whether the next generation of cancer nanomedicines fulfills its clinical promise.